Interestingly, nearly 89.0% of non-optimally controlled GLP-1RA users received treatment intensification during follow-up, whereas only half of GLP-1RA non-users who did not achieve optimal glycaemic control received intensified therapy
Meanwhile, lawmakers in Louisiana are debating whether to allow Medicaid to cover GLP-1s for obesity treatment if enrollees have another chronic condition, or comorbidity, such as prediabetes, hypertension or cardiovascular disease
9 Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023
Researchers can design them to fit biological targets with considerable precision, and pharmaceutical companies have developed peptide medicines for diabetes, cancer, osteoporosis and other conditions
It is classified as a potent antioxidant with demonstrated effects on lipid metabolism, insulin sensitivity, and inflammation in both animal and human studies
In the body, NAC helps break down mucus for easier clearance